{"ticker": {"uuid": "dde769e7-6501-4809-8099-0e9ba18c0c14", "symbol": "MD", "name": "Mednax Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Care Facilities"}, "articles": [{"title": "Pediatrix reaffirms $280\u2013$300 million EBITDA outlook", "summary": "Pediatrix Medical Group (NYSE:MD) has reaffirmed its 2026 Adjusted EBITDA outlook of $280\u2013$300 million, despite other healthcare companies reporting unfavorable shifts. The company stated its second-quarter payor mix remained stable, matching historical trends and internal expect", "url": "https://grafa.com/en/news/united-states/pediatrix-reaffirms-2026-ebitda-outlook", "source_name": "grafa.com", "published_at": "2026-07-15T11:13:00", "published_display": "15 Jul 2026 11:13", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group (NYSE: MD) keeps 2026 EBITDA view as payor mix holds", "summary": "Pediatrix Medical Group (NYSE: MD) has reaffirmed its full-year 2026 Adjusted EBITDA outlook of $280 million to $300 million, stating that its second-quarter 2026 payor mix remained stable despite adverse trends reported elsewhere in the healthcare sector. The company also confir", "url": "https://www.stocktitan.net/sec-filings/MD/8-k-pediatrix-medical-group-inc-reports-material-event-8e8a7ae74d61.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:11:07", "published_display": "15 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group Provides Second Quarter Update", "summary": "Pediatrix Medical Group, Inc. (NYSE: MD) provided an update on its second-quarter 2026 business trends, confirming that its payor mix remained stable and it has not experienced unfavorable payor mix shifts reported by other healthcare participants. The company reaffirmed its full", "url": "https://ca.finance.yahoo.com/news/pediatrix-medical-group-provides-second-105000892.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T11:11:07", "published_display": "15 Jul 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group (NYSE: MD) 5.1% stake held via Dimensional funds", "summary": "Dimensional Fund Advisors LP has disclosed a significant stake in Pediatrix Medical Group Inc. (NYSE: MD), beneficially owning 4,220,311 shares, which represents 5.1% of the outstanding common stock. The filing, a SCHEDULE 13G, indicates Dimensional holds sole voting power over 4", "url": "https://www.stocktitan.net/sec-filings/MD/schedule-13g-pediatrix-medical-group-inc-passive-investment-disclosur-83bb865342b8.html", "source_name": "Stock Titan", "published_at": "2026-07-14T17:10:54", "published_display": "14 Jul 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Pediatrix (MD) Joining Russell Defensive Indexes Recast Its Profile as a Value-Safe Haven?", "summary": "Pediatrix Medical Group (NYSE: MD) was recently added to the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, a move that could broaden its investor base and trading liquidity. While this inclusion suggests a perception of the company as a defensive health", "url": "https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/does-pediatrix-md-joining-russell-defensive-indexes-recast-i", "source_name": "Simply Wall Street", "published_at": "2026-07-03T03:40:34", "published_display": "03 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Defensive Index", "summary": "Pediatrix Medical Group, Inc. (NYSE: MD) has been added to the Russell 2000 Defensive Index. This news follows several recent updates for the company, including UBS adjusting its price target and the release of their Q1 2026 earnings report, which showed increased adjusted earnin", "url": "https://www.marketscreener.com/news/pediatrix-medical-group-inc-nyse-md-added-to-russell-2000-defensive-index-ce7f5fddd88ffe25", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:10:35", "published_display": "29 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Value-Defensive Index", "summary": "Pediatrix Medical Group, Inc. (NYSE: MD) has been added to the Russell 2000 Value-Defensive Index. This announcement highlights the company's inclusion in a significant market index, reflecting its established presence in the healthcare sector. The article also provides recent ne", "url": "https://www.marketscreener.com/news/pediatrix-medical-group-inc-nyse-md-added-to-russell-2000-value-defensive-index-ce7f5fdedb8dff25", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T02:12:50", "published_display": "29 Jun 2026 02:12", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Pediatrix Medical Group, Inc. \u2013 NYSE:MD", "summary": "This article provides financial data specifically focusing on the \"Enterprise value to EBITDA forward\" for Pediatrix Medical Group, Inc. (NYSE: MD). The content appears to be a stub or a data point from a financial platform like TradingView, indicating no available value or chang", "url": "https://www.tradingview.com/symbols/NYSE-MD/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T02:09:47", "published_display": "26 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group, Inc. Actuals & Estimates (NYSE:MD)", "summary": "This article provides key financial data and analyst estimates for Pediatrix Medical Group, Inc. (NYSE:MD). It covers the company's stock performance, market capitalization, earnings, revenue, and future outlook based on analyst forecasts, as well as general information for poten", "url": "https://www.tradingview.com/symbols/NYSE-MD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T15:39:33", "published_display": "25 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Pediatrix Medical Group, Inc. \u2013 NYSE:MD", "summary": "This article provides the \"Price to earnings forward\" value for Pediatrix Medical Group, Inc. (NYSE: MD), a company in the Health Services sector. It states that the market is closed with no trades recorded for this specific financial metric. The article is primarily a data point", "url": "https://www.tradingview.com/symbols/NYSE-MD/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T13:39:33", "published_display": "25 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group (MD) Stock Price, News & Analysis $MD", "summary": "Pediatrix Medical Group (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal, and pediatric subspecialty care. The company currently has a \"Hold\" consensus rating from analysts, with a price target of $22.50, suggesting a potenti", "url": "https://www.marketbeat.com/stocks/NYSE/MD/", "source_name": "MarketBeat", "published_at": "2026-06-22T12:10:58", "published_display": "22 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group Stock - Weekly move and sector check after quiet news flow", "summary": "Pediatrix Medical Group (MD) stock saw a modest gain this week with quiet news flow, broadly tracking the US healthcare services sector. The company, which provides physician services in neonatal and maternal-fetal care, is characterized as a defensive healthcare exposure. Its ma", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/pediatrix-medical-group-stock-weekly-move-and-sector-check-after-quiet/69584557", "source_name": "AD HOC NEWS", "published_at": "2026-06-19T17:09:13", "published_display": "19 Jun 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Roundup: Pediatrix Medical Group (NYSE:MD) And The Rest Of The Healthcare Providers & Services Segment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPQ1gzV2czdUplNlB2b2F3ZFlLNEMtS3ZRMmUzVFFucEZoYTNKZk9NZ25VQUFfVUNrM3VFXzVpTVo2RjZRTnlNQnJxSnY2ZVVESzhlMlNNSkV3aV9NQmM3S2ZCRWZROFBHM1VwVzY1clBvdS1zdzdrSFR6cTBqMlZoUFRBdERTY1F0SlMyU29QRkNtdjVPd1hWLWVXZjJBcFQxWHRRTXRjdlZBM2tNR3JqQi1icWwtWUF5RDdVeVRpZERjZTRCX3JTR2lJcU9ock1oWmlnRjcxQml3MzM2RmNpV0d1RzJpZFZsdjdHUGMyWE1NZ3JNTnNlNHp4OA?oc=5", "source_name": "StockStory", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDNAX, Inc. (MD) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9xUWpJaExlLWF0SEpkWHgyM0NtV2RYQ25HVWdHdmluWVpBRWgyRE1aNlFra2FkM0FXM3Y4S1NndVVtS0NyVnhvVTNWUlpza3Aya09fOA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T00:24:12+00:00", "published_display": "13 Jan 2026 00:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Pediatrix reaffirms $280\u2013$300 million EBITDA outlook", "summary": "Pediatrix Medical Group (NYSE:MD) has reaffirmed its 2026 Adjusted EBITDA outlook of $280\u2013$300 million, despite other healthcare companies reporting unfavorable shifts. The company stated its second-quarter payor mix remained stable, matching historical trends and internal expect", "url": "https://grafa.com/en/news/united-states/pediatrix-reaffirms-2026-ebitda-outlook", "source_name": "grafa.com", "published_at": "2026-07-15T11:13:00", "published_display": "15 Jul 2026 11:13", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group (NYSE: MD) keeps 2026 EBITDA view as payor mix holds", "summary": "Pediatrix Medical Group (NYSE: MD) has reaffirmed its full-year 2026 Adjusted EBITDA outlook of $280 million to $300 million, stating that its second-quarter 2026 payor mix remained stable despite adverse trends reported elsewhere in the healthcare sector. The company also confir", "url": "https://www.stocktitan.net/sec-filings/MD/8-k-pediatrix-medical-group-inc-reports-material-event-8e8a7ae74d61.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:11:07", "published_display": "15 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group Provides Second Quarter Update", "summary": "Pediatrix Medical Group, Inc. (NYSE: MD) provided an update on its second-quarter 2026 business trends, confirming that its payor mix remained stable and it has not experienced unfavorable payor mix shifts reported by other healthcare participants. The company reaffirmed its full", "url": "https://ca.finance.yahoo.com/news/pediatrix-medical-group-provides-second-105000892.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T11:11:07", "published_display": "15 Jul 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group (NYSE: MD) 5.1% stake held via Dimensional funds", "summary": "Dimensional Fund Advisors LP has disclosed a significant stake in Pediatrix Medical Group Inc. (NYSE: MD), beneficially owning 4,220,311 shares, which represents 5.1% of the outstanding common stock. The filing, a SCHEDULE 13G, indicates Dimensional holds sole voting power over 4", "url": "https://www.stocktitan.net/sec-filings/MD/schedule-13g-pediatrix-medical-group-inc-passive-investment-disclosur-83bb865342b8.html", "source_name": "Stock Titan", "published_at": "2026-07-14T17:10:54", "published_display": "14 Jul 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Pediatrix (MD) Joining Russell Defensive Indexes Recast Its Profile as a Value-Safe Haven?", "summary": "Pediatrix Medical Group (NYSE: MD) was recently added to the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, a move that could broaden its investor base and trading liquidity. While this inclusion suggests a perception of the company as a defensive health", "url": "https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/does-pediatrix-md-joining-russell-defensive-indexes-recast-i", "source_name": "Simply Wall Street", "published_at": "2026-07-03T03:40:34", "published_display": "03 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Defensive Index", "summary": "Pediatrix Medical Group, Inc. (NYSE: MD) has been added to the Russell 2000 Defensive Index. This news follows several recent updates for the company, including UBS adjusting its price target and the release of their Q1 2026 earnings report, which showed increased adjusted earnin", "url": "https://www.marketscreener.com/news/pediatrix-medical-group-inc-nyse-md-added-to-russell-2000-defensive-index-ce7f5fddd88ffe25", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:10:35", "published_display": "29 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Value-Defensive Index", "summary": "Pediatrix Medical Group, Inc. (NYSE: MD) has been added to the Russell 2000 Value-Defensive Index. This announcement highlights the company's inclusion in a significant market index, reflecting its established presence in the healthcare sector. The article also provides recent ne", "url": "https://www.marketscreener.com/news/pediatrix-medical-group-inc-nyse-md-added-to-russell-2000-value-defensive-index-ce7f5fdedb8dff25", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T02:12:50", "published_display": "29 Jun 2026 02:12", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Pediatrix Medical Group, Inc. \u2013 NYSE:MD", "summary": "This article provides financial data specifically focusing on the \"Enterprise value to EBITDA forward\" for Pediatrix Medical Group, Inc. (NYSE: MD). The content appears to be a stub or a data point from a financial platform like TradingView, indicating no available value or chang", "url": "https://www.tradingview.com/symbols/NYSE-MD/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T02:09:47", "published_display": "26 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group, Inc. Actuals & Estimates (NYSE:MD)", "summary": "This article provides key financial data and analyst estimates for Pediatrix Medical Group, Inc. (NYSE:MD). It covers the company's stock performance, market capitalization, earnings, revenue, and future outlook based on analyst forecasts, as well as general information for poten", "url": "https://www.tradingview.com/symbols/NYSE-MD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T15:39:33", "published_display": "25 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Pediatrix Medical Group, Inc. \u2013 NYSE:MD", "summary": "This article provides the \"Price to earnings forward\" value for Pediatrix Medical Group, Inc. (NYSE: MD), a company in the Health Services sector. It states that the market is closed with no trades recorded for this specific financial metric. The article is primarily a data point", "url": "https://www.tradingview.com/symbols/NYSE-MD/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T13:39:33", "published_display": "25 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group (MD) Stock Price, News & Analysis $MD", "summary": "Pediatrix Medical Group (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal, and pediatric subspecialty care. The company currently has a \"Hold\" consensus rating from analysts, with a price target of $22.50, suggesting a potenti", "url": "https://www.marketbeat.com/stocks/NYSE/MD/", "source_name": "MarketBeat", "published_at": "2026-06-22T12:10:58", "published_display": "22 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatrix Medical Group Stock - Weekly move and sector check after quiet news flow", "summary": "Pediatrix Medical Group (MD) stock saw a modest gain this week with quiet news flow, broadly tracking the US healthcare services sector. The company, which provides physician services in neonatal and maternal-fetal care, is characterized as a defensive healthcare exposure. Its ma", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/pediatrix-medical-group-stock-weekly-move-and-sector-check-after-quiet/69584557", "source_name": "AD HOC NEWS", "published_at": "2026-06-19T17:09:13", "published_display": "19 Jun 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Roundup: Pediatrix Medical Group (NYSE:MD) And The Rest Of The Healthcare Providers & Services Segment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPQ1gzV2czdUplNlB2b2F3ZFlLNEMtS3ZRMmUzVFFucEZoYTNKZk9NZ25VQUFfVUNrM3VFXzVpTVo2RjZRTnlNQnJxSnY2ZVVESzhlMlNNSkV3aV9NQmM3S2ZCRWZROFBHM1VwVzY1clBvdS1zdzdrSFR6cTBqMlZoUFRBdERTY1F0SlMyU29QRkNtdjVPd1hWLWVXZjJBcFQxWHRRTXRjdlZBM2tNR3JqQi1icWwtWUF5RDdVeVRpZERjZTRCX3JTR2lJcU9ock1oWmlnRjcxQml3MzM2RmNpV0d1RzJpZFZsdjdHUGMyWE1NZ3JNTnNlNHp4OA?oc=5", "source_name": "StockStory", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDNAX, Inc. (MD) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9xUWpJaExlLWF0SEpkWHgyM0NtV2RYQ25HVWdHdmluWVpBRWgyRE1aNlFra2FkM0FXM3Y4S1NndVVtS0NyVnhvVTNWUlpza3Aya09fOA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T00:24:12+00:00", "published_display": "13 Jan 2026 00:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 14, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 9, "score": 55, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 72, "events": [{"event": "earnings", "label": "Earnings", "weight": 2.75, "count": 5}, {"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 26.27, "latest_week": "2026-07-10", "one_week_move": -1.8, "four_week_move": 8.1, "twelve_week_move": 13.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.057751, "market_dynamics_buy_signal": false, "relative_strength": 17.700266, "fair_value_gap": 81.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 44.7226, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.8% over one week, +8.1% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "www.marketscreener.com", "count": 2}, {"label": "grafa.com", "count": 1}, {"label": "Yahoo! Finance Canada", "count": 1}, {"label": "Simply Wall Street", "count": 1}, {"label": "MarketBeat", "count": 1}, {"label": "AD HOC NEWS", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 5}, {"label": "Market update", "count": 4}, {"label": "Guidance", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.8% over one week, +8.1% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Pediatrix reaffirms $280\u2013$300 million EBITDA outlook"}], "updated_at": "2026-07-16T12:57:06.487807+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}